Recent Buy ABBV
03 Jul 2018 22:48
Tags
Friday I started a small position in AbbVie (ABBV) by grabbing shares at a price of $92.93/share and a dividend yield of 4.13%. Pharmaceutical companies have been pressured for the last 6 weeks with some strong names like Johnson & Johnson (JNJ) and Pfizer (PFE) facing decreasing or stagnating share price.
All three companies (ABBV, JNJ, PFE) are currently decent buys and it is tough to choose. However, from a dividend growth perspective, you can’t go wrong with any of these three. I choose ABBV because I already have sizeable positions in JNJ, PFE, as well as Merck (MRK) which surprisingly has held up well over the last 6 weeks.
Comments: 2
page revision: 2, last edited: 03 Jul 2018 22:50
Post preview:
Close previewI’ve looked at pharma companies but never pulled the trigger. Now that soon I will get free trades again from Merrill edge it will be easier to buy something monthly and get into that field. Can’t go wrong with ABBV JNJ or PFE.
Gotta love those free trades.